Key result
PFO is not linked to higher recurrent cerebral ischemia risk after young cryptogenic stroke.
Why the study?
Does the presence of a patent foramen ovale increase the risk of recurrent stroke in young cryptogenic stroke patients receiving aspirin?
Cohort (n=186)
Does the presence of a patent foramen ovale increase the risk of recurrent stroke in young cryptogenic stroke patients receiving aspirin?
Young patients with cryptogenic stroke have a low long-term recurrence rate on aspirin therapy, and the presence of a PFO does not increase this risk.
Supports aspirin monotherapy without PFO closure in young cryptogenic stroke; leaves open randomized closure trials in this aspirin-treated cohort.
BACKGROUND: Among patients with a patent foramen ovale and cryptogenic ischemic stroke, the long-term prognosis is unclear. AIMS: This study aims to estimate the recurrence rate in young cryptogenic stroke patients with and without patent foramen ovale. PATIENTS AND METHODS: One hundred eighty-six cryptogenic stroke patients (aged 18-45 years) were prospectively followed for up to five-years. They were divided into two groups according to the echocardiographic presence of patent foramen ovale. All patients received aspirin (100 mg/day) for secondary prevention. RESULTS: Mean age was 32·3 (standard deviation 7·9) years. During the mean follow-up of 66 months five patients with patent foramen ovale had recurrent strokes compared with 11 patients without patent foramen ovale. The average annual rate of recurrent cerebral ischemia was 1·1% and 1·6% for patients with and without patent foramen ovale, respectively. The recurrence rate did not increase with the presence of patent foramen ovale, atrial septal aneurysm or other variables. More than 60% of the reported cases achieved a good functional outcome. CONCLUSIONS: Young patients with cryptogenic ischemic stroke with and without patent foramen ovale have a low recurrence rate in a long-term follow-up and most present a favorable outcome. Patent foramen ovale with or without atrial septal aneurysm did not increase the risk of recurrence.
No takes yet. Share an insight, caveat, or question.
Araúz et al. (2011) conducted a cohort in cryptogenic ischemic stroke (n=186). Patent foramen ovale vs. Without patent foramen ovale was evaluated on Recurrent cerebral ischemia. The presence of a patent foramen ovale in young patients with cryptogenic stroke did not increase the risk of recurrent cerebral ischemia compared to those without PFO (annual rate 1.1% vs 1.6%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from International Journal of Stroke